Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Celmatrix Corporation is navigating 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The prosecution is currently handled by a distinct examiner and 1 distinct art unit, showing a narrow focus for the company's filings. GREENE, IVAN A serves as the busiest examiner, currently reviewing the pending matter.
With only a single art unit involved, the legal team can focus on the specific examination standards of that administrative group. This centralization helps in maintaining a consistent prosecution history for the pending matter. For a practitioner, this means that the technical arguments do not need to account for the varying interpretations often found across different art units. The current structure allows for a more direct dialogue with the USPTO.
The presence of a single examiner for the entire pending portfolio allows for a more efficient resolution of technical rejections. The applicant only needs to satisfy the requirements of the assigned official, which can lead to a more predictable examination timeline. The strategy remains focused on the specific precedents and practices of the Biotechnology & Pharmaceuticals sector while ensuring that all communications with the patent office are unified.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GREENE, IVAN A | 1 | 18.7% | +6.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18513527 | BEVERAGE COMPOSITIONS FOR HYDRATION AND FOR SUPPORT OF HAIR HEALTH | GREENE, IVAN A | — |
| Art Unit | Apps |
|---|---|
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18513527 | BEVERAGE COMPOSITIONS FOR HYDRATION AND FOR SUPPORT OF HAIR HEALTH | GREENE, IVAN A | 1619 | §102§103§112Other | Non-Final OA | — | Pending | Nov 18, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial